new tirzepatide drug FDA approves version of diabetes Mounjaro to be sold for weight loss FDA approval for Zepbound (tirzepatide)
Description
Transitioning Between GLP-1 Medications and Dosing Strategies If Wegovy discontinuation has already caused weight regain, restarting GLP-1 therapy often works again, though it may take slightly longer to reach the same appetite suppression if you stopped for several months
Nutritional Support As appetite is decreased, nutrient intake often decreases
Other systemic symptoms, depending on individual response
Nausea was the most common type of GI adverse event, followed by diarrhea, the researchers wrote
Do I need to follow a specific diet while taking Semaglutide or Tirzepatide
